Livzon Pharmaceutical Group Inc 2020 SR
The report highlights Livzon Pharmaceutical Group's sustainability efforts in 2020, focusing on its response to the COVID-19 pandemic through donations and the development of diagnostic kits. The company established an ESG committee to oversee its sustainable development and set environmental management goals for 2021-2025. Key achievements include a 3% reduction in greenhouse gas emissions and significant investments in R&D, particularly for innovative drugs and rare disease treatments. Livzon also emphasized talent development, achieving a 47.5% female employee ratio, and continued its health-based poverty alleviation programs across several Chinese provinces.
Company: Livzon Pharmaceutical Group Inc
Sector: Manufacturing
Country: China
Year: 2020
Type: SR
Pages: 138
Back to company
Livzon Pharmaceutical Group Inc
ESG Report
The report highlights Livzon Pharmaceutical Group's sustainability efforts in 2020, focusing on its response to the COVID-19 pandemic through donations and the development of diagnostic kits. The company established an ESG committee to oversee its sustainable development and set environmental management goals for 2021-2025. Key achievements include a 3% reduction in greenhouse gas emissions and significant investments in R&D, particularly for innovative drugs and rare disease treatments. Livzon also emphasized talent development, achieving a 47.5% female employee ratio, and continued its health-based poverty alleviation programs across several Chinese provinces.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Water Consumption
Total Waste
Employees